peroxynitrous acid has been researched along with naltrindole in 1 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (naltrindole) | Trials (naltrindole) | Recent Studies (post-2010) (naltrindole) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 801 | 0 | 139 |
Protein | Taxonomy | peroxynitrous acid (IC50) | naltrindole (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.0007 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.0006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Discala, JF; Gruber, RB; Lewis, SJ; May, WJ; McLaughlin, D; Palmer, LA; Young, AP | 1 |
1 other study(ies) available for peroxynitrous acid and naltrindole
Article | Year |
---|---|
Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite.
Topics: Analysis of Variance; Animals; Antidotes; Drug Tolerance; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Penicillamine; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiratory Insufficiency; Time Factors | 2013 |